Journal of Clinical and Translational Hepatology

The Journal of Clinical and Translational Hepatology (J CLIN TRANSL HEPATO, ISSN: 2225-0719) is a leading, peer-reviewed, open-access journal dedicated to advancing the understanding and management of liver diseases. Published by XIA & HE Publishing Inc., the journal serves as a premier platform for disseminating high-quality research that bridges the gap between laboratory discoveries and clinical applications. Its scope encompasses the full spectrum of hepatology, including viral hepatitis, non-alcoholic fatty liver disease, alcoholic liver disease, cirrhosis, hepatocellular carcinoma, cholestatic and autoimmune liver diseases, liver transplantation, and metabolic disorders affecting the liver. The journal also emphasizes translational studies, such as biomarker discovery, drug development, and novel therapeutic strategies. It publishes a diverse array of article types, including original research articles, comprehensive reviews, systematic reviews and meta-analyses, editorials, case reports, and concise letters to the editor. The target audience includes hepatologists, gastroenterologists, infectious disease specialists, transplant surgeons, pharmacologists, and researchers in basic and translational hepatology. A standout feature of the journal is its open-access model, ensuring that all published content is freely and permanently available online, promoting global dissemination of knowledge without subscription barriers. With an impressive 2026 Impact Factor of 6.0000, the journal is ranked in the prestigious JCR Q1 quartile, placing it among the top-tier publications in its field. This high impact factor and quartile ranking underscore its significant influence and reputation as a key resource for cutting-edge, clinically relevant hepatology research.